Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Adapting To An Evolving Health Care System: IOM Report Maps Plan For U.S.

This article was originally published in The Gray Sheet

Executive Summary

Major advances in health care technology have contributed to making the U.S. health care system complex, costly and inefficient, but technology can also be part of the solution, according to a report from the Institute of Medicine.

You may also be interested in...

IOM Wants More Government Oversight For Health Information Technology

FDA Device Reviews Need Stronger Patient Safety Criteria - IoM Report

FDA's Center for Devices and Radiological Health should place greater emphasis on patient safety in actual use and real-life settings when approving medical devices, the Institute of Medicine concludes in a report on medical errors, "To Err is Human," released Nov. 30.

Keeping Track: Return & Renewal At US FDA

Takeda’s TAK-721 is back, ARS Pharma will be back soon to appeal neffy complete response letter, US FDA’s Project Renewal brings Temodar labeling in current day, and more highlights from the Pink Sheet’s US FDA Performance Tracker.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts